Friday, July 31, 2026

Cheongung-II Exercise Highlights Expanded Role in South Korea’s Layered Air Defense

South Korea's Cheongung-II missile system enhances defense against mixed aerial threats with rapid interception capabilities.

How Terraform Labs Misled Thousands of Investors

The prosecution submitted to the court a...

THE FORBIDDEN ENGINE : Seoul’s High-Stakes Gamble To Break Nuclear Chains For Total Retaliation

South Korea's Defense Ministry is researching laws for nuclear submarines and IAEA safeguard exemptions to support military nuclear fuel acquisition.

Jung Eun Kim

Author's Latest

Samsung Biologics Strengthens Global Partnerships at Decat Week 2026: Key Insights and Strategies

Samsung Biologics aims to enhance global partnerships at J.P. Morgan's Healthcare Conference 2026, showcasing its CDMO strengths.

Celltrion’s 1 Trillion KRW Investment: A Game Changer for Biopharmaceutical Production by 2030

Celltrion plans a major expansion with over 1 trillion KRW investment, boosting production capacity for biosimilars and new drugs by 2030.

Top 5 Innovations at KIMES 2026: Why Global Buyers Are Flocking to South Korea’s Healthcare Expo

KIMES 2026 in Seoul showcased a surge in international interest for Korean medical devices, highlighting AI and digital healthcare advancements.

How Rasmotinib and PHI-501 Could Revolutionize Cancer Treatment: Insights from Bio Europe Spring 2026

Pharos iBio showcases its cancer treatments at Bio Europe Spring 2026, seeking global partnerships for Rasmotinib and PHI-501.

NovaCell Technology Passes KOSDAQ Evaluation: What This Means for DongKoo BioPharm’s Future

Donggu Bio Pharmaceutical announces that its invested company, Novacell Technologies, has passed the technical evaluation for KOSDAQ listing.

Discover Classys’ Game-Changing Elle Ray Laser: A Hybrid Solution for Aesthetic Medicine in 2026

Classys to unveil Elle Ray, a next-gen laser device, at KIMES 2026, enhancing safety in treatments with innovative technology.

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

SK Bioscience Pours 4 Billion KRW into RSM01, Accelerating RSV Antibody Trials

SK Bioscience secures funding from the Light Foundation to support clinical trials for its RSV prevention monoclonal antibody RSM01.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

Wave Global: Innovative Medical Solutions Unveiled at Wontech’s Seoul Event for Global Expansion

Wontech will host the Wave Global event in Seoul on March 21, marking a strategic push for global expansion and engagement.

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Samsung Biologics Partners with Eli Lilly: How This Open Innovation Hub Will Transform K-Bio by 2027

Samsung Biologics partners with Eli Lilly to create a biotech innovation hub in Korea, enhancing growth opportunities for local firms.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.